PMV Pharmaceuticals
Amy W. has extensive experience in the pharmaceutical industry, currently serving as a Clinical Trial Manager, Clinical Trial Associate, and Research Scientist at PMV Pharmaceuticals, Inc. since January 2018. Prior to this, Amy was employed at Bristol-Myers Squibb from November 1999 to December 2017 as a Research Scientist, focusing on drug development and target validation for pre-clinical oncology programs, and conducting various studies involving rodents. Amy holds a Master of Science in Molecular Biology from Georgian Court University (2004-2008) and a Bachelor of Science in Biology from the University of Pittsburgh (1995-1999).
PMV Pharmaceuticals
1 followers
PMV Pharmaceuticals, Inc. is developing first-in-class p53 regulators for the treatment of cancer. PMV Pharma combines unique biological understanding with pharmaceutical development focus.